Hempamericana Announces Plans to Be Current With OTC Markets
NEW YORK, NY / ACCESSWIRE / July 20, 2021 / HEMPAMERICANA (OTC PINK:HMPQ) is in the process of completing its financials and plans to be current with OTC markets very soon.
HEMPAMERICANA produces CBD FULL SPECTRUM by using CO2 subcritical extraction - the slowest and cleanest extraction method available. HMPQ produces the “Real McCoy” of CBD, with no additives and nothing taken out, and has over 37600 bottles available for sale. The company has all of the trials needed to produce more formulas and has just lowered its pricing for several products. For more information, please visit hempamericana.com.
PR Contact info:
View source version on accesswire.com:
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Smart Eye22.10.2021 08:51:53 CEST | Press release
Interim Report January - September 2021
CTT Systems AB21.10.2021 15:03:07 CEST | Press release
Changes in the Nomination Committee for CTT Systems AB
ITOCO Inc.21.10.2021 13:32:20 CEST | Press release
ITOCO Welcomes Maria Teresa Tattersfield Yarza to Its Board of Directors and Carbon Credit Advisory Board
XVIVO Perfusion AB21.10.2021 08:06:47 CEST | Press release
XVIVO Presents Interim Report January-September 2021
Ximen Mining Corp.21.10.2021 05:31:49 CEST | Press release
Ximen Mining Corp Closes Recently Announced Financings
Champions Oncology, Inc.20.10.2021 16:28:12 CEST | Press release
Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus
Physitrack20.10.2021 09:12:03 CEST | Press release
Physitrack PLC – Interim report: December 2020 – August 2021
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom